Patent details

Basic Information

Publication number:

EP3427752

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181889924

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English Title of Invention:

STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES

French Title of Invention:

FORMULATIONS STABILISÉES CONTENANT DES ANTICORPS ANTI-NGF

German Title of Invention:

STABILISIERTE FORMULIERUNGEN MIT ANTI-NGF-ANTIKÖRPERN

SPC Number:

Dates

Filing date:

11/07/2011

Grant date:

28/04/2021

EP Publication Date:

16/01/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/04/2021

EP B1 Publication Date:

28/04/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/07/2021

Expiration date:

11/07/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/04/2021

 

 

Name:

Regeneron Pharmaceuticals, Inc.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:

POTOCKY, Terra

Address:

United States (US)

2

Name:

WALSH, Scott

Address:

United States (US)

3

Name:

DIX, Daniel

Address:

United States (US)

4

Name:

SIVENDRAN, Renuka

Address:

United States (US)

Priority

Priority Number:

36411210 P

Priority Date:

14/07/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; C07K 16/22;

Publication

European Patent Bulletin

Issue number:

202117

Publication date:

28/04/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages